KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Shares Outstanding (2016 - 2025)

Globus Medical's Shares Outstanding history spans 15 years, with the latest figure at $112.6 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 402.12% year-over-year to $112.6 million; the TTM value through Dec 2025 reached $112.6 million, up 402.12%, while the annual FY2025 figure was $112.6 million, 402.12% up from the prior year.
  • Shares Outstanding reached $22.4 million in Q4 2025 per GMED's latest filing, down from $112.2 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $118.2 million in Q3 2023 to a low of $22.4 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $68.4 million, with a median of $77.7 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding: skyrocketed 407.83% in 2023, then plummeted 80.31% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $22.4 million in 2021, then changed by 0.0% to $22.4 million in 2022, then surged by 407.83% to $113.9 million in 2023, then tumbled by 80.31% to $22.4 million in 2024, then soared by 402.12% to $112.6 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Shares Outstanding are $112.6 million (Q4 2025), $22.4 million (Q3 2025), and $22.4 million (Q2 2025).